Wolverine Trading’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.78M Sell
37,929
-10,101
-21% -$671K ﹤0.01% 1887
2025
Q2
$2.51M Buy
48,030
+34,306
+250% +$1.95M ﹤0.01% 1536
2025
Q1
$876K Sell
13,724
-10,601
-44% -$616K ﹤0.01% 2375
2024
Q4
$1.17M Buy
24,325
+6,163
+34% +$316K ﹤0.01% 2502
2024
Q3
$1.03M Buy
+18,162
New +$1.04M ﹤0.01% 2315
2023
Q4
Sell
-5,691
Closed -$214K 4773
2023
Q3
$217K Buy
+5,691
New +$233K ﹤0.01% 3657
2021
Q2
Sell
-4,999
Closed -$221K 6276
2021
Q1
$205K Buy
+4,999
New +$228K ﹤0.01% 5022
2020
Q3
Sell
-11,856
Closed -$330K 4776
2020
Q2
$306K Buy
+11,856
New +$267K ﹤0.01% 3319
2019
Q3
Sell
-10,093
Closed -$166K 4605
2019
Q2
$173K Sell
10,093
-2,741
-21% -$44.2K ﹤0.01% 3792
2019
Q1
$207K Sell
12,834
-19,855
-61% -$322K ﹤0.01% 3787
2018
Q4
$467K Buy
32,689
+2,834
+9% +$45.2K ﹤0.01% 2702
2018
Q3
$542K Sell
29,855
-11,348
-28% -$199K ﹤0.01% 3026
2018
Q2
$807K Hold
41,203
﹤0.01% 2494
2018
Q1
$807K Buy
41,203
+27,362
+198% +$530K ﹤0.01% 2494
2017
Q4
$280K Sell
13,841
-367
-3% -$6.75K ﹤0.01% 3722
2017
Q3
$247K Sell
14,208
-3,403
-19% -$46.1K ﹤0.01% 3542
2017
Q2
$229K Sell
17,611
-22,811
-56% -$305K ﹤0.01% 3420
2017
Q1
$527K Buy
+40,422
New +$511K ﹤0.01% 2324

Other funds holding HALO

Wolverine Trading's HALO Position: Q3 2025 in Review

Wolverine Trading reduced its Halozyme (HALO) stake by 21% in Q3 2025, selling an estimated $671K and leaving 37,929 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1887.

Wolverine Trading first reported a position in HALO in Q1 2017 and has held it in 18 quarters since. 602 funds tracked by Wall St. Rank hold HALO as of Q3 2025.

  • Wolverine Trading held 37,929 shares of Halozyme worth $2.78M as of Q3 2025.
  • Wolverine Trading sold 10,101 Halozyme shares in Q3 2025, an estimated $671K.
  • Halozyme made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #1887 holding.
  • Wolverine Trading first reported a position in Halozyme in Q1 2017 and has held it in 18 quarters since.
  • 602 funds tracked by Wall St. Rank held Halozyme as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.